β-thalassemia Testing Post

Utility of the Beta-thalassemia mode on the G7

The Beta-thalassemia analysis mode on the G7 analyzer is used to confirm the identity of a hemoglobin variant for an HbA1c result and to screen for Beta-thalassemia and other hemoglobinopathies. For example, people with thalassemia can develop diabetes and a hemoglobin variant may interfere with their HbA1c result. Also, transfusion patients need to see a decrease in a specific hemoglobin variant. Furthermore, Hereditary Persistent Fetal Hemoglobin (HPFH) patients have high HbF above 20%.

Alternate methodologies (i.e. electrophoresis) usually require a combination of at least two techniques, one qualitative and one quantitative. As a result, these methodologies are time, labor and cost intensive. Tosoh would like you to know that the Beta-thalassemia mode on the G7 analyzer is a faster, easier and less expensive way for presumptive identification of hemoglobinopathies.

The University of Virginia Medical Center runs 600 samples/year, and uses the G7 Beta-thalassemia mode because it is faster than electrophoresis: “The Beta- thalassemia program on the G7 has reduced my turnaround time from 7 days to 24 hours”- Walter Oliveira.

Hemoglobinopathies may interfere with an HbA1c result which merits further investigation. Please contact your local System Sales Specialist to learn how you can help provide better patient care.

rated 4 by 1 users.